---
title: "NRXN1"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Gene NRXN1"
tags: ['NRXN1', 'SynapticProteins', 'NeurexinFamily', 'DevelopmentalDisorders', 'Schizophrenia', 'AutismSpectrumDisorder', 'IntellectualDisability', 'Antipsychotics']
---

# Gene NRXN1

## Gene Information
- Function: NRXN1 encodes a member of the neurexin family of synaptic proteins which are responsible for maintaining the synaptic function and interaction between neurons.
- External IDs:
    - Gene ID: 9378
    - Genomic Location: Chromosome 2p16.3
    - Aliases: KIAA0712, NRXN

## Databases
- HGNC: 8033
- NCBI Entrez: [9378]([Click](https://www.ncbi.nlm.nih.gov/gene/9378))
- Ensembl: [ENSG00000176719]([Click](https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000176719;r=2p16.3))
- OMIM: [600565]([Click](https://omim.org/entry/600565))
- UniProtKB/Swiss-Prot: [Q9H3S7]([Click](https://www.uniprot.org/uniprot/Q9H3S7))

## Mutations
- AA Mutation:
    - Type: Missense
    - dbSNP ID: rs121907968
- Somatic SNVs/InDels:
    - dbSNP ID: rs754246819
    
## Related Disease
- NRXN1 is associated with several developmental disorders including:
    - Schizophrenia
    - Autism Spectrum Disorder
    - Intellectual disability
    - Epilepsy
    - Depression
    - Congenital Heart Diseases
    
## Treatment and Prognosis
- There is no cure for NRXN1-related disorders but treatment is symptomatic depending on the severity of the disorder. In some cases, medications such as antipsychotics, mood stabilizers, and antidepressants may be used to manage the symptoms of the disorder.
- The prognosis for NRXN1-related disorders varies depending on the severity of the disorder and the efficacy of the treatment.

## Drug response
- The use of antipsychotics and mood stabilizers can help improve the symptoms of NRXN-related disorders such as Schizophrenia and Autism Spectrum Disorder.

## References
- Gauthier, J., Siddiqui, T. J., Huashan, P., Yokomaku, D., Hamdan, F. F., Champagne, N., ... & Fathalli, F. (2011). Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Human genetics, 130(4), 563-573. [PubMed: 21750922]
- Zahir, F. R., Baross, A., Delaney, A. D., Eydoux, P., Fernandes, N. D., Pugh, T., ... & Marra, M. A. (2008). A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1Î±. Journal of medical genetics, 45(4), 239-243. [PubMed: 18234728]

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**